11/14/2024
6:00 AM | MiNK Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2024
8:15 AM | MiNK Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
7:18 AM | Corvese Brian (Reporting)
MiNK Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
7:22 AM | MiNK Therapeutics (Issuer)
WIINBERG ULF (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
7:23 AM | Behner Peter (Reporting)
MiNK Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
7:23 AM | MiNK Therapeutics (Issuer)
Ryan Barbara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2024
11:15 PM | MiNK Therapeutics (Filer)
| Form EFFECT | |
|
08/16/2024
3:39 PM | MiNK Therapeutics (Filer)
| Form 424B3 | |
08/13/2024
3:34 PM | MiNK Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/13/2024
3:18 PM | MiNK Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/13/2024
6:00 AM | MiNK Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2024
1:22 PM | Corvese Brian (Reporting)
MiNK Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
1:24 PM | MiNK Therapeutics (Issuer)
WIINBERG ULF (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
1:27 PM | MiNK Therapeutics (Issuer)
Ryan Barbara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
1:27 PM | Behner Peter (Reporting)
MiNK Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
3:33 PM | GKCC, LLC (Filed by)
MiNK Therapeutics (Subject)
| Form SC 13G | |
05/16/2024
7:02 AM | MiNK Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
6:30 AM | MiNK Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
6:28 AM | MiNK Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/29/2024
4:25 PM | MiNK Therapeutics (Filer)
| Form DEF 14A | |
03/21/2024
6:00 AM | MiNK Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2024
5:00 PM | Corvese Brian (Reporting)
MiNK Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
5:00 PM | MiNK Therapeutics (Issuer)
WIINBERG ULF (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
5:00 PM | MiNK Therapeutics (Issuer)
Ryan Barbara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
5:00 PM | Behner Peter (Reporting)
MiNK Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
3:05 PM | MiNK Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
5:05 PM | ARMEN GARO H (Filed by)
MiNK Therapeutics (Subject)
| Form SC 13D | |
02/14/2024
7:00 AM | MiNK Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/18/2024
7:00 PM | Buell Jennifer (Reporting)
MiNK Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
7:00 PM | MiNK Therapeutics (Issuer)
van Dijk Marcus Antonius (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
5:05 PM | Behner Peter (Reporting)
MiNK Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
5:05 PM | MiNK Therapeutics (Issuer)
WIINBERG ULF (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
5:05 PM | Corvese Brian (Reporting)
MiNK Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
5:11 PM | MiNK Therapeutics (Issuer)
Ryan Barbara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
